Wyeth Launches Vaccine for Pneumococcal Disease in India

by Medindia Content Team on  July 4, 2006 at 8:35 AM Drug News   - G J E 4
Wyeth Launches Vaccine for Pneumococcal Disease in India
Global pharma major Wyeth Tuesday launched its blockbuster vaccine Prevenar in India to help prevent invasive pneumococcal disease among infants and toddlers.

Pneumococcal disease is a group of illnesses caused by streptococcus pneumoniae, also known as the "pneumococcus" bacteria.

Prevenar is a seven-valent vaccine that is expected to prevent pneumococcal diseases like sepsis, meningitis, bacterial pneumonia, septicaemia and bacteraemia (bacteria in the blood).

Infants and children are at the greatest risk for invasive pneumococcal disease as 25-60 percent of them are carriers of pneumococci in their throats. The risks of meningitis and bacteremia are greatest during the first two years of a child.

"It's been a long journey but we are delighted to announce that Prevenar is now in India to protect children from invasive pneumococcal disease responsible for many cases of childhood mortality and morbidity," Ranga Iyer, managing director of Wyeth, said in a statement.

Prevenar is used worldwide and is now part of the regular immunisation schedule in many countries. Available in 75 countries, since the licensure of Prevenar in 2000, 30-40 million children have been protected against the disease.

Priced at around Rs.3,300 per vial in India at par with global prices, Prevenar is administered in three doses to children below two years at the sixth, 10th and 14th weeks after birth and a booster dose at 12 to 15 months.

(Source: IANS)

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
can this vaccine be given to a children of six month, as he has not taken any shot so far, also he has becterial pneumonia
vihaan Friday, October 1, 2010
My child is one year old can is it possible to vaccinate Pneumococcal vaccine now?
Noorul Monday, March 29, 2010
What is the effectivness of this vaccine. Is it really required for small kids. Some say that it has side effects in terms of asthma.
NavinS Tuesday, January 12, 2010
My daughter 8 months has not been given any of Pneumococcal vaccine then what scheduele has to be followed for the same????
SwatiVritti Monday, November 16, 2009
you can get "catch up vaccination" done. Catch up vaccination – 6-12 months: 2 doses at 4-8 weeks apart and 1 booster at 15-18 months
guest Monday, January 11, 2010
What is the effectivness of this vaccine. Is it really required for small kids. some says that it has side effect in terms of asthma.
NavinS Tuesday, January 12, 2010
Does this vaccine has any adverse effects likw rheumatic fever. Can we get a brief idea about how it works? Sunday, January 18, 2009
Prevenar is enjoying a monopoly market and leadership pricing because of the product patent regime in India. Can we invoke COMPULSORY LICENSING for this product in our country and create competition? This will reduce the prices and the vaccine can be given to more people. Remember Shantha Biotech introduced Hepatitis B vaccine at 0.50 USD when the leader vaccine was 15 USD.
guest Monday, August 25, 2008
very very useful and efective vaccine. but the price is quite high. so please discuss regarding that so that even poors can be benefited.
guest Monday, July 28, 2008

You May Also Like